Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study

被引:124
作者
Bui, L
Rempel, E
Reeson, D
Simunovic, M
机构
[1] Juravinski Canc Ctr, Hamilton, ON L8V 5C2, Canada
[2] McMaster Univ, Fac Hlth Sci, Dept Surg, Hamilton, ON, Canada
关键词
outcomes; pathology; understaging; colon cancer; surgery;
D O I
10.1002/jso.20499
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: This Study assessed lymph node counts, lymph node status (positive or negative), and survival among patients undergoing colon cancer surgery in Ontario. Canada. Methods: We obtained data from the Ontario Cancer Registry on 960 patients who underwent a major colon cancer resection in years 1991-1993. Patients and hospitals were ranked by lymph node count to correlate lymph node Counts and lymph node status. For node-negative patients we assessed the influence of patient, hospital, and tumor factors on lymph node counts and survival. Results: The rate of node-positive patients was similar among the lymph node count groups. For example, the odds ratio of a patient being node positive if the lymph node count was 10-36 versus 1-3 was 1.0 (CI 0.6-1.6, P = 0.42). Among node-negative patients, Survival was improved for patients with a high (10-36) versus low (1-3) lymph node count (HR 0.6, CI 0.4-1.0, P = 0.03). No patient, hospital, or tumor factors predicted both a higher lymph node count and improved survival. Conclusions: In this population-based study of patients undergoing colon cancer surgery, higher lymph node Counts did not correlate with increased rates of node-positive status.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 33 条
[1]  
[Anonymous], 1996, ICES PRACTICE ATLAS, P339
[2]  
[Anonymous], 2002, AJCC Cancer Staging Manual
[3]  
[Anonymous], SEER CANC STAT REV 1
[4]  
Caplin S, 1998, CANCER, V83, P666, DOI 10.1002/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.3.CO
[5]  
2-S
[6]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
[7]   Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? [J].
Cserni, G ;
Vinh-Hung, V ;
Burzykowski, T .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 81 (02) :63-69
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]  
Gafà R, 2000, CANCER, V89, P2025, DOI 10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.0.CO
[10]  
2-S